Dianthus Therapeutics, Inc. (DNTH) vs Merit Medical Systems, Inc. (MMSI)
A side-by-side comparison of Dianthus Therapeutics, Inc. and Merit Medical Systems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DNTH
Dianthus Therapeutics, Inc.
$86.18HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
MMSI
Merit Medical Systems, Inc.
$85.28HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — DNTH vs MMSI
growth of $100 · dividends reinvested · last 8yDNTH -62.1% (-11.4%/yr)MMSI +73.4% (+7.1%/yr)MMSI compounded faster over this window
DNTH MMSI
DNTH vs MMSI: by the numbers
- •MMSI is the larger company ($5.09B vs $4.82B market cap).
- •MMSI is profitable (9.22% net margin) while DNTH runs a net loss (-1570.85%).
Metrics side by side
Valuation
| Metric | DNTH | MMSI |
|---|---|---|
| P/E ratio | N/A | 35.24 |
| Forward P/E | N/A | 19.82 |
| P/S ratio | 2531.79 | 3.22 |
| P/B ratio | 4.11 | 3.03 |
| EV / EBITDA | N/A | 16.20 |
| FCF yield | N/A | 4.00% |
Profitability
| Metric | DNTH | MMSI |
|---|---|---|
| Gross margin | 96.01% | 49.52% |
| Operating margin | -8739.34% | 12.75% |
| Net margin | -1570.85% | 9.22% |
| ROE | -2.55% | 8.67% |
| ROIC | -18.48% | 5.80% |
Growth (annualized)
| Metric | DNTH | MMSI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 8.90% |
| FCF CAGR (5Y) | N/A | 8.96% |
| Total return CAGR (5Y) | -5.50% | 3.88% |
Frequently asked
- Is DNTH or MMSI more profitable?
- MMSI runs the higher net margin — DNTH at -1570.85% versus MMSI at 9.22%.
- How have DNTH and MMSI total returns compared?
- Over the past 5 years, DNTH delivered -5.50% and MMSI delivered 3.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Merit Medical Systems P/E ratioDianthus Therapeutics ROEMerit Medical Systems ROEDianthus Therapeutics operating marginMerit Medical Systems operating marginDianthus Therapeutics revenue growthMerit Medical Systems revenue growthDianthus Therapeutics free cash flowMerit Medical Systems free cash flow
Dianthus Therapeutics & Merit Medical Systems appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.